1989
DOI: 10.1016/0014-5793(89)81023-3
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cells

Abstract: 5′‐[32P]‐labelled alkylating decathymidylate [4‐(N‐2‐chloroethyl)N‐methylaminobenzyl]‐5′‐phosphamide derivatives containing cholesterol or phenazinium residues at their 3′‐termini were synthesized and used for alkylation of DNA within mammalian cells. The uptake of the cholesterol derivative by the cells and the extent of DNA alkylation are about two orders of magnitude higher than those of a similar alkylating derivative lacking the groups at the 3′‐termini. The presence of the phenazinium residue at the 3′‐t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
74
0

Year Published

1994
1994
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 149 publications
(74 citation statements)
references
References 9 publications
(3 reference statements)
0
74
0
Order By: Relevance
“…In particular, for the same number density and lipid composition, 5Ј-Poly T / 3Ј-Poly A 24-mers gave a much higher yield of lipid and content mixing than a fully overlapping complementary sequence pair (22). Related results have been reported using more complex, double cholesterol-anchored-DNA conjugates (23,24) [singly anchored cholesterol-DNA conjugates, which have been proposed for drug delivery purposes (25), partition only transiently to lipid bilayers or vesicles in contrast to the anchor shown in Fig. 4].…”
mentioning
confidence: 73%
“…In particular, for the same number density and lipid composition, 5Ј-Poly T / 3Ј-Poly A 24-mers gave a much higher yield of lipid and content mixing than a fully overlapping complementary sequence pair (22). Related results have been reported using more complex, double cholesterol-anchored-DNA conjugates (23,24) [singly anchored cholesterol-DNA conjugates, which have been proposed for drug delivery purposes (25), partition only transiently to lipid bilayers or vesicles in contrast to the anchor shown in Fig. 4].…”
mentioning
confidence: 73%
“…These telomerase inhibitory effects of the oligonucleotides, however, were significantly more profound in vitro in the presence of a transfection reagent. Several modifications of oligonucleotides, such as lipid or cellpenetrating peptide conjugates, have been suggested to improve oligonucleotide in vitro activity (Boutorin et al, 1989;Letsinger et al, 1989;Shea et al, 1990;Farooqui et al, 1991;Reed et al, 1991;Stein et al, 1991;MacKellar et al, 1992;Oberhauser and Wagner, 1992;Polushin and Cohen, 1994;Mishra et al, 1995). In particular, cholesterol modification of phosphorothioate oligonucleotides has been shown to improve inhibition of HIV replication (Letsinger et al, 1989;Farooqui et al, 1991;Stein et al, 1991).…”
mentioning
confidence: 99%
“…Many studies have examined the ability of cholesteryl-conjugated oligonucleotides to associate with cells and effects on efficacy. These studies examined the uptake and effects of cholesteryl-rnodified antisense oligonucleotides in transformed fibroblasts or lymphocytes (Reed etal., 1995;Zhang et al, 1995;Boutorin et al, 1989;Kreig et aI., 1993). In this report we have investigated antiviral activity and cellular uptake in normal human cells, which seem to display different characteristics with respect to uptake and subcellular distribution in that most of the oligonucleotide remains in the cytoplasm in uninfected cells.…”
Section: Discussionmentioning
confidence: 99%